Development and Evaluation of a Line Probe Assay for Rapid Identification of pncA Mutations in Pyrazinamide-Resistant Mycobacterium tuberculosis Strains
Author(s) -
Junichiro Sekiguchi,
Tomohiko Nakamura,
Tohru MiyoshiAkiyama,
Fumiko Kirikae,
Intetsu Kobayashi,
Ewa AugustynowiczKopeć,
Zofia Zwolska,
Koji Morita,
Toshinori Suetake,
Hiroshi Yoshida,
Seiya Kato,
Toru Mori,
Teruo Kirikae
Publication year - 2007
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.00352-07
Subject(s) - pyrazinamide , mycobacterium tuberculosis , tuberculosis , microbiology and biotechnology , biology , drug resistance , virology , medicine , pathology
Resistance ofMycobacterium tuberculosis to pyrazinamide (PZA) derives mainly from mutations in thepncA gene. We developed a reverse hybridization-based line probe assay with oligonucleotide probes designed to detect mutations inpncA . The detection of PZA resistance was evaluated in 258 clinical isolates ofM. tuberculosis . The sensitivity and specificity of PZA resistance obtained by this new assay were both 100%, consistent with the results of conventional PZA susceptibility testing. This assay can be used with sputa from tuberculosis patients. It appears to be reliable and widely applicable and, given its simplicity and rapid performance, will be a valuable tool for diagnostic use.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom